Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taipei Exchange - Delayed Quote TWD

Wiltrom Co., Ltd. (6767.TWO)

Compare
32.35
+0.35
+(1.09%)
At close: April 2 at 1:24:17 PM GMT+8
Loading Chart for 6767.TWO
  • Previous Close 32.00
  • Open 32.25
  • Bid 32.60 x --
  • Ask 33.75 x --
  • Day's Range 32.25 - 32.60
  • 52 Week Range 28.50 - 42.00
  • Volume 10,130
  • Avg. Volume 14,534
  • Market Cap (intraday) 1.268B
  • Beta (5Y Monthly) 0.54
  • PE Ratio (TTM) --
  • EPS (TTM) -1.62
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Wiltrom Co., Ltd. researches, develops, manufactures, and sells a range of implantable medical devices in Taiwan and internationally. The company's products include spinal fixation systems, interbody fusion systems, bone graft substitutes, vertebral body augmentation systems, and vertebroplasty bone cement. Wiltrom Co., Ltd. was founded in 2009 and is based in Zhubei, Taiwan.

www.wiltrom.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 6767.TWO

View More

Performance Overview: 6767.TWO

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6767.TWO
10.39%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.54%

1-Year Return

6767.TWO
16.08%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
4.06%

3-Year Return

6767.TWO
0.46%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
20.84%

5-Year Return

6767.TWO
40.04%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
120.40%

Compare To: 6767.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6767.TWO

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    1.27B

  • Enterprise Value

    966.75M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.79

  • Price/Book (mrq)

    2.14

  • Enterprise Value/Revenue

    2.89

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -8.55%

  • Return on Assets (ttm)

    -3.83%

  • Return on Equity (ttm)

    -6.76%

  • Revenue (ttm)

    291.62M

  • Net Income Avi to Common (ttm)

    -24.93M

  • Diluted EPS (ttm)

    -1.62

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    141.75M

  • Total Debt/Equity (mrq)

    25.25%

  • Levered Free Cash Flow (ttm)

    -37.57M

Research Analysis: 6767.TWO

View More

Company Insights: 6767.TWO

Research Reports: 6767.TWO

View More

People Also Watch